Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Common Stock | Options Exercise | $581K | +75K | +39.39% | $7.74 | 265K | Sep 10, 2024 | Direct | F1 |
transaction | EVRI | Common Stock | Sale | -$983K | -75K | -28.26% | $13.10 | 190K | Sep 10, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Stock Option | Options Exercise | -$581K | -75K | -100% | $7.74 | 0 | Sep 10, 2024 | Common Stock | 75K | $7.74 | Direct | F3 |
Id | Content |
---|---|
F1 | The transactions reflected in this Form 4 were for stock options originally granted on April 22, 2015 that would have expired within the next eight months on April 22, 2025. |
F2 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $13.09 to $13.12. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | Represents an option to purchase 75,000 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant of April 22, 2015. |